Cargando…
A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache
The objective was to measure the cost of botulinum toxin type A (BTX-A) treatment of chronic tension-type headache. A prospective pharmaceutical costing analysis was completed in the Day Hospital of the Regional Referral Headache Centre at Sant’Andrea Hospital in Rome, chronic tension-type headache...
Autores principales: | Palazzo, Fabio, Mennini, Francesco G., Fioravanti, Laura, Piasini, Laura, Coloprisco, Gabriella, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452170/ http://dx.doi.org/10.1007/s10194-004-0100-3 |
Ejemplares similares
-
A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache
por: Mennini, Francesco S., et al.
Publicado: (2004) -
Reduction in expenditures on
analgesics during one year of treatment of chronic tension
headache with BoNT-A
por: Coloprisco, Gabriella, et al.
Publicado: (2003) -
Long-term benefits of botulinum toxin type A
(BOTOX) in chronic daily headache: a five-year
long experience
por: Farinelli, I., et al.
Publicado: (2006) -
Botulinum toxin injections for the treatment of frontal tension headache
por: Kokoska, Mimi S., et al.
Publicado: (2004) -
Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache centre
por: Negro, Andrea, et al.
Publicado: (2020)